Benzoic acid, 2-hydroxy-, calcium salt (2:1)
CAS 824-35-1
Benzoic acid, 2-hydroxy-, calcium salt (2:1) (CAS 824-35-1) is a pharmaceutical compound with 0 bioactivity targets and 188 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Benzoic acid, 2-hydroxy-, calcium salt (2:1) is linked to DTXSID60890489 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Benzoic acid, 2-hydroxy-, calcium salt (2:1) used for in pharmaceutical contexts?
Benzoic acid, 2-hydroxy-, calcium salt (2:1) (CAS 824-35-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Benzoic acid, 2-hydroxy-, calcium salt (2:1)?
Benzoic acid, 2-hydroxy-, calcium salt (2:1) has 188 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Benzoic acid, 2-hydroxy-, calcium salt (2:1) also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Salicylate with EU status "restricted".
What clinical phase is Benzoic acid, 2-hydroxy-, calcium salt (2:1) in?
No phase 1-4 clinical development badge is rendered for Benzoic acid, 2-hydroxy-, calcium salt (2:1) because the matched compound identifier rows do not contain a max-phase value.